Haverford, PA, United States of America

Woonbok Chung

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Texas System. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Woonbok Chung. Retrieved from https://idiyas.com/inventor/woonbok-chung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Woonbok Chung: Innovator in Bladder Cancer Detection

Introduction

Woonbok Chung is a notable inventor based in Haverford, PA (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of bladder cancer. His innovative approach utilizes genetic markers to improve the accuracy of cancer detection.

Latest Patents

Woonbok Chung holds a patent for the "Detection of bladder cancer." This patent outlines methods for detecting bladder cancer in a subject. Specifically, it evaluates the methylation of one or more genes, including MYO3A, CA10, NKX6-2, SOX11, DBC1, NPTX2, and A2BP1, in DNA sediment from a urine sample. This method aims to determine the presence or absence of bladder cancer in human patients.

Career Highlights

Chung is affiliated with the University of Texas System, where he continues to advance research in cancer detection technologies. His work is pivotal in enhancing early diagnosis, which is crucial for effective treatment.

Collaborations

Woonbok Chung has collaborated with esteemed colleagues such as Bogdan A Czerniak and Jean-Pierre J Issa. These partnerships have fostered a collaborative environment that promotes innovative research in cancer diagnostics.

Conclusion

Woonbok Chung's contributions to bladder cancer detection exemplify the impact of innovative research in medicine. His work not only advances scientific knowledge but also holds the potential to improve patient outcomes significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…